{"count": 1, "results": [{"_id": "36151773", "pmid": 36151773, "pmcid": "PMC9972017", "title": "A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation", "journal": "Cancer Med", "authors": ["Metts JL", "Trucco M", "Weiser DA", "Thompson P", "Sandler E", "Smith T", "Crimella J", "Sansil S", "Thapa R", "Fridley BL", "Llosa N", "Badgett T", "Gorlick R", "Reed D", "Gill J"], "date": "2022-09-23T00:00:00Z", "doi": "10.1002/cam4.5297", "meta_date_publication": "2022 Sep 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.625, "text_hl": "Concurrently to the @DISEASE_Precursor_Cell_Lymphoblastic_Leukemia_Lymphoma @DISEASE_MESH:D054198 @@@ALL@@@ trial, and based on preclinical evidence of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ anticancer activity and the lack of established dosing tolerance in adults, we sought to determine the safety and tolerability of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ when combined with VIT in relapsed and refractory pediatric solid and @<m>DISEASE_Central_Nervous_System_Neoplasms</m> @DISEASE_MESH:D016543 @@@CNS tumors@@@.", "citations": {"NLM": "Metts JL, Trucco M, Weiser DA, Thompson P, Sandler E, Smith T, Crimella J, Sansil S, Thapa R, Fridley BL, Llosa N, Badgett T, Gorlick R, Reed D, Gill J. A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation Cancer Med. 2022 Sep 23;():. PMID: 36151773", "BibTeX": "@article{36151773, title={A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation}, author={Metts JL and Trucco M and Weiser DA and Thompson P and Sandler E and Smith T and Crimella J and Sansil S and Thapa R and Fridley BL and Llosa N and Badgett T and Gorlick R and Reed D and Gill J}, journal={Cancer Med}}"}}]}